Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
13 results
D1.149 - Murine IgG1 increased y subcutaneous immunotherapy suppressed development of allergic asthma
D1.150 - Study design for the saFety assessment of an Accelerated up-dosing scheme using one Strength of a native house dust mite allergen extract for subcutaneous immunoTherapy in children with allergic asthma in China (FAST II study)
D1.153 - Protocol for a randomized, 5-arm study to evaluate the combination of omalizumab and allergen immunotherapy in patients with asthma due to house dust mites
D1.154 - Safety of ultra-rush immunotherapy starting protocol with the molecular extract Diater Alt a 1 mol mix
- D3.03 - Trend analysis of the occurrence of allergic diseases in Polish children over the past 30 years
- D3.05 - Predictive Value of Bronchodilator Reversibility and FeNO in Assessing Positive Outcomes of Bronchial Provocation Tests in Asthma Patients
- D3.02 - Benefits of non-invasive methods in the diagnosis of occupational asthma: example of asthma due to ammonium persulphate in a hairdresser
- D3.07 - Allergic Asthma in Children: The Hidden Role of Cockroaches
- D3.10 - Systemic characteristic of 15-LOX and 5-LOX oxo-metabolites in older patients with aspirin exacerbated respiratory disease
- D3.11 - Bird-Egg Syndrome and Beyond: Exploring Allergies to Egg Yolk and Seeds from Bird Feed Components
- D3.12 - A case of Pneumothorax as first manifestation of asthma
- D3.13 - Real-life experience with tezepelumab in severe allergic asthma
- D3.14 - Validation of an environmental exposure chamber for the diagnosis of olive tree pollen allergy
Download the app
The congress at your fingertips
Available on
Download